You are viewing: UK Injection Pen Market analysis
Part of: Injection Pen Market (Global)

The UK Injection Pen Market was valued at $1095.9 Million in 2024 and projected to reach to $1691 Million by 2029, representing a compound annual growth rate of 7.5%. The UK injection pen market is positioned for sustained growth through 2029, driven by the rising burden of chronic diseases and a shift towards patient-centric healthcare delivery.

UK Injection Pen Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Injection Pen Market Trends and Insights

  • The UK market is driven by rising prevalence of chronic diseases such as diabetes and autoimmune disorders, coupled with increasing patient preference for self-administered injectable therapies.
  • In the UK, regulatory support from the MHRA and NHS adoption of advanced pen devices are accelerating market penetration across both primary and secondary care settings. The UK injection pen market benefits from strong healthcare infrastructure and high awareness of injectable treatment options among UK healthcare professionals and patients.
  • The UK's aging population and growing incidence of biologics-based therapies are key factors supporting the 7.5% compound annual growth rate through 2029.
  • Additionally, the UK market is witnessing innovation in needle technology and smart pen devices that enhance patient compliance and data tracking capabilities..

Key Market Statistics

  • CAGR (2024-2029) 7.5% CAGR
  • Market Size, 2024 ~USD 1095.9 Million
  • Forecast, 2029 ~USD 1691 Million
  • Country UK

UK Injection Pen Market Overview

Market Valuation :

The UK injection pen market is valued at £1,095.9 million in 2024, with a projected CAGR of 7.5% through 2029, reaching £1,691 million by forecast end.

Chronic Disease Prevalence :

Rising incidence of diabetes and autoimmune disorders in the UK population is driving demand for self-administered injectable therapies and pen-based delivery systems.

Regulatory Support :

The MHRA's regulatory framework and NHS adoption of injection pen technologies are accelerating market penetration and reimbursement across UK healthcare systems.

Patient Preference Shift :

UK patients increasingly favour self-administered injectable treatments over traditional methods, boosting adoption of user-friendly injection pen devices.

UK Injection Pen Market Dynamics

  • NHS initiatives promoting self-management of conditions like diabetes and rheumatoid arthritis are expanding the addressable market.
  • Technological advancements in pen design, coupled with improved ease-of-use features, are enhancing patient compliance and treatment outcomes across the UK. Regulatory support from the MHRA and increasing healthcare expenditure on injectable therapies will further accelerate market expansion.
  • The UK's ageing population and growing prevalence of autoimmune conditions create sustained demand for injection pen solutions.
  • Market players investing in NHS partnerships and patient education programmes are well-positioned to capture growth opportunities in this expanding segment..

Related Ecosystem

Drug Delivery Devices

Top Technologies
  • Disposable Autoinjectors
  • Reusable Autoinjectors
  • Insulin Pumps
  • Pen Injectors
  • Transdermal Patches
Top Companies
  • Novo nordisk a/s
  • Becton, Dickinson and Company
  • Terumo Corporation
  • Medtronic plc
  • Nipro Corporation

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • The UK injection pen market is valued at £1,095.9 million in 2024 and is projected to reach £1,691 million by 2029, representing a 7.5% CAGR.
      • The UK market is driven by increasing prevalence of diabetes and autoimmune diseases, with strong NHS support for injectable therapies.
      • The UK healthcare system's regulatory framework and aging population are key growth catalysts for advanced injection pen adoption.
      • Innovation in smart pen technology and needle design is enhancing patient compliance and market expansion across the UK.

      Injection Pen Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment REUSABLE INJECTION PENS (Type)
      Forecast Period 2024-2029
      Growth Rate CAGR of 7.9% from 2024 to 2029
      Largest Segment HOME CARE SETTINGS (End User)
      Market Size Base Year (Billions) ~USD 46.96 (2024)
      Revenue Forecast (Billions) ~USD 68.67 (2029)
      Segments Covered Type, Therapy, End User

      UK Injection Pen Market Report Segmentation

      3 segment dimensions are covered across the global market.

      By Type

      • Disposable Injection Pen
      • Disposable Injection Pens
      • Glp-1
      • Glucagon-Like Peptide-1 (Glp-1)
      • Insulin
      • Reusable Injection Pen
      • Reusable Injection Pens

      By Therapy

      • Diabetes
      • Fertility
      • Growth Hormone
      • Growth Hormone Therapy
      • Obesity
      • Osteoporosis
      • Other Therapies

      By End User

      • Home Care Settings
      • Hospitals & Clinics

      UK: INJECTION PEN MARKET, BY END USER, 2022–2030

      Segment202220232024202520262027202820292030CAGR (%)
      HOME CARE SETTINGS999.61089.41170.21259.11356.81464.115821711.31853.38
      HOSPITALS & CLINICS121.5129.4135.9142.9150.5158.8167.8177.4187.85.5
      TOTAL1121.11218.81306.114021507.31622.91749.71888.72041.27.7

      Target Audience

      • Pharmaceutical Manufacturers : UK-based and international pharma companies need market sizing, competitive intelligence, and NHS pathway insights to develop and commercialise injection pen products in Britain.
      • Medical Device Companies : Device manufacturers require UK-specific regulatory guidance, market entry strategies, and healthcare provider adoption data to successfully launch injection pen innovations.
      • Healthcare Providers & NHS Trusts : Hospital procurement teams and NHS commissioners need market analysis to evaluate injection pen options, assess cost-effectiveness, and optimise patient care delivery.
      • Investment & Private Equity Firms : Investors evaluating UK healthcare opportunities require detailed market forecasts, growth drivers, and competitive dynamics to assess injection pen sector investment potential.
      • Healthcare Consultants & Advisors : Strategy consultants supporting UK healthcare clients need comprehensive market data, trend analysis, and regulatory insights to inform clinical and commercial recommendations.

      Reasons to Buy this Report

      • NHS Market Intelligence : Gain detailed insights into NHS procurement patterns, reimbursement policies, and adoption rates for injection pen technologies across UK healthcare trusts and primary care settings.
      • Competitive Landscape Analysis : Understand UK-specific competitive positioning, market share distribution among leading manufacturers, and emerging players targeting the British injection pen market.
      • Regulatory & Compliance Framework : Access comprehensive guidance on MHRA approval pathways, UK regulatory requirements, and compliance standards essential for market entry and product commercialisation.
      • Patient Segmentation Data : Identify UK patient demographics, disease prevalence by region, treatment preferences, and adoption barriers to tailor marketing and distribution strategies effectively.
      • Growth Opportunity Mapping : Discover high-growth therapeutic areas, underserved regions within the UK, and emerging clinical indications driving demand for next-generation injection pen solutions.

      Frequently asked questions

      What is the current size of the UK injection pen market?

      The UK injection pen market was valued at £1,095.9 million in 2024 and is expected to grow to £1,691 million by 2029.

      What is the growth rate of the UK injection pen market?

      The UK injection pen market is projected to grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2029.

      What are the main drivers of growth in the UK injection pen market?

      Key drivers include rising prevalence of diabetes and autoimmune disorders in the UK, NHS adoption of advanced pen devices, regulatory support, and growing patient preference for self-administered therapies.

      How is the UK injection pen market expected to evolve by 2029?

      By 2029, the UK market will likely see increased adoption of smart pen technologies, expanded NHS coverage, and greater penetration of biologics-based therapies across the UK healthcare system.

      What factors are influencing injection pen adoption in the UK?

      The UK's aging population, strong healthcare infrastructure, regulatory support from the MHRA, innovation in needle technology, and increased awareness among UK healthcare professionals are key adoption factors.

      RESEARCH METHODOLOGY

      This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

      Secondary Research

      The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), European Federation of Pharmaceutical Industries and Associations (EFPIA), American Journal of Drug Delivery and Therapeutics, International Diabetes Federation (IDF), American Association of Diabetes Educators (AADE, Asian Association for the Study of Diabetes (AASD) and Parenteral Drug Association (PDA) were referred to identify and collect information for the global injection pen market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the injection pen market. The primary sources from the demand side include hospitals & clinics and home care settings. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

      A breakdown of the primary respondents is provided below:

      Injection  Pens Market Size, and Share

      *C-level primaries include CEOs, CFOs, COOs, and VPs.

      *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

      Note: Companies are classified into tiers based on their total revenue. As of 2022, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

      Source: MarketsandMarkets Analysis

      To know about the assumptions considered for the study, download the pdf brochure

      Market Estimation Methodology

      For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global injection pen market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players (who contribute at least 70-75% of the market share at the global level). Also, the global injection pen  market was split into various segments and sub-segments based on:

      • List of major players operating in the injection pen  products market at the regional and/or country level
      • Product mapping of various injection pen  manufacturers at the regional and/or country level
      • Mapping of annual revenue generated by listed major players from injection pen(or the nearest reported business unit/product category)
      • Revenue mapping of major players to cover at least 70-75% of the global market share as of 2023
      • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
      • Summation of the market value of all segments/subsegments to arrive at the global point-of-care  diagnostics market

      Illustrative example of Novo Nordisk A/S: Revenue Share Analysis, 2023

      Injection  Pens Market Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

      Data Triangulation

      After arriving at the overall size of the global Injection pen market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

      Market Definition

      Injection pens are used by patients or self-administering drugs for the treatment of various diseases such as diabetes, osteoporosis, growth hormone deficiency, obesity, fertility and among others. These medical devices are easy to handle and cost-effective for patients.

      Stakeholders

      • Injection Pen Manufacturing Companies
      • Pharmaceutical Companies (Drug Manufacturers)
      • Original Equipment Manufacturing Companies   
      • Suppliers and Distributors of Injection Pens
      • Healthcare Service Providers
      • Teaching Hospitals and Academic Medical Centers
      • Health Insurance Players
      • Government Bodies/Municipal Corporations
      • Regulatory Bodies
      • Medical Research Institutes
      • Business Research and Consulting Service Providers
      • Venture Capitalists
      • Market Research and Consulting Firms

      Report Objectives

      • To define, measure, and describe the global injection pen market by type, therapy, end user, and region
      • To provide detailed information about the major factors influencing the market growth (drivers, restraints, challenges, and opportunities)
      • To strategically analyze the regulatory scenario, pricing, value chain analysis, supply chain analysis, ecosystem analysis, technology analysis, Porter’s Five Forces analysis, and patent analysis
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
      • To strategically analyze the market structure, profile the key players in the global injection pen market, and comprehensively analyze their core competencies
      • To track and analyze company developments such as acquisitions, partnerships, expansions, and product launches and approvals in the injection pen market
      • To track and analyze competitive developments such as mergers and acquisitions, new product developments, partnerships, agreements, collaborations, and expansions in the global injection pen  market

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

      Geographic Analysis

      • Further breakdown of the Rest of Europe injection pen market into Russia, Switzerland, Denmark, Austria, and others
      • Further breakdown of the Rest of Asia Pacific injection pen market into South Korea, Taiwan, and others
      • Further breakdown of the Rest of Latin America injection pen market into Argentina, Colombia, Chile, Ecuador, and others
      • Further breakdown of the Southeast Asia injection pen market into Malaysia, Singapore, Australia, New Zealand, and others

      Competitive Landscape Assessment

      • Market share analysis, by region (North America and Europe), which provides market shares of the top 3-5 key players in the injection pen market
      • Competitive leadership mapping for established players in the US

      Get the Full Injection Pen Market Report

      Full forecast, segment splits, and company analysis for all Injection Pen Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status